NEW YORK – CellChorus said on Thursday that it has received a $2.5 million grant from the National Institutes of Health.

纽约——CellChorus周四表示，它已获得美国国立卫生研究院（National Institutes of Health）250万美元的资助。

The Small Business Innovation Research Fast-Track grant awarded by the National Center for Advancing Translational Sciences will fund development of the firm's TIMING (time-lapse imaging microscopy in nanowell grids) technology for single-cell analysis.

国家转化科学促进中心授予的小企业创新研究快速通道基金将资助该公司用于单细胞分析的定时（纳米孔网格中的延时成像显微镜）技术的开发。

The $350,000 Phase I grant is underway, and a two-year $2.1 million Phase II grant will begin after CellChorus achieves certain predetermined milestones.

35万美元的第一阶段拨款正在进行中，两年210万美元的第二阶段拨款将在CellChorus达到某些预定的里程碑后开始。

'While many cell therapies have been approved and are in development, the industry needs an integrated analytical platform that provides a matrix of functional readouts including cell phenotype and metabolism on the same cells over time,' Rebecca Berdeaux, VP of science at CellChorus, said in a statement..

CellChorus科学副总裁丽贝卡·贝多（RebeccaBerdeaux）在一份声明中说：“虽然许多细胞疗法已经获得批准并正在开发中，但该行业需要一个集成的分析平台，该平台可以提供功能读数矩阵，包括随时间推移同一细胞的细胞表型和代谢。”。。

The Houston-based firm's TIMING platform, which it offers as a service, quantifies how immune cells move, interact, kill, survive, and secrete biomolecules at single-cell resolution.

这家总部位于休斯顿的公司提供的计时平台是一项服务，它可以量化免疫细胞如何以单细胞分辨率移动，相互作用，杀死，存活和分泌生物分子。

The award follows a $274,000 grant in 2023 from the National Institute of General Medical Sciences.

该奖项是在2023年美国国家普通医学科学研究所（National Institute of General Medical Sciences）提供274000美元赠款之后获得的。